醫院感染控制市場規模、佔有率和成長分析（按產品、應用、技術、疾病、最終用戶和地區）- 產業預測 2025-2032

醫院感染控制市場預計將在 2023 年達到 304 億美元，從 2024 年的 326.2 億美元成長到 2032 年的 573.2 億美元，預測期內（2025-2032 年）的複合年成長率為 7.3%。

由於幾個關鍵促進因素，醫院內感染 (HAI) 市場正在經歷強勁成長。這一趨勢的核心是提高人們對減少醫療環境中交叉感染和感染疾病傳播的必要性的認知。政府積極加強感染預防措施正在進一步加速市場擴張。在醫院、地區和國家層級實施嚴格的感染預防標準，有利於在醫療環境中形成安全和衛生的文化。此外，擴大採用監測解決方案至關重要，因為它們使醫療保健提供者能夠採取主動措施有效地預防和管理醫院感染，從而增強整體努力，改善病患安全和健康結果。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

醫院感染控制市場規模（按產品和服務）

• 市場概況
• 保護屏障
• 消毒
• 消毒劑
  • 產品
  • 乾洗手劑
  • 表面消毒劑
  • 皮膚消毒劑
  • 器械消毒劑
  • 配方
  • 液體消毒劑
  • 消毒紙巾
  • 消毒噴霧
• 消毒劑
• 內視鏡再處理產品
• 其他感染控制產品

醫院感染控制市場規模（按應用）

• 市場概況
• 疾病檢測
• 抗藥性檢測

醫院感染控制市場規模（按技術）

• 市場概況
• 表現型分析
• 基因分型方法

醫院感染控制市場規模（按疾病）

• 市場概況
• 醫院內後天性肺炎
• 血流感染疾病
• 手術部位感染疾病
• 胃腸道感染疾病
• 尿道感染
• 其他

醫院感染控制市場規模（依最終用戶分類）

• 市場概況
• 醫院及重症監護室
• 門診手術及診斷中心
• 安養院及婦產中心
• 其他

醫院感染控制市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• 3M Company（United States）
• Becton, Dickinson and Company（BD）（United States）
• bioMerieux SA（France）
• Ecolab Inc.（United States）
• Getinge AB（Sweden）
• Advanced Sterilization Products（ASP）（United States）
• Belimed AG（Switzerland）
• Matachana Group（Spain）
• MMM Group（Germany）
• Reckitt Benckiser Group plc（United Kingdom）
• Metrex Research LLC（United States）
• Miele Group（Germany）
• Pal International（United Kingdom）
• Melag Medizintechnik GmbH & Co. KG（Germany）
• Contec, Inc.（United States）
• MEDALKAN（Greece）
• Systec GmbH（Germany）
• CBMSrl Medical Equipment（Italy）
• Continental Equipment Company（United States）
• BGS Beta-Gamma-Service GmbH & Co. KG（Germany）

結論和建議

Hospital-Acquired Infection Control Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 32.62 billion in 2024 to USD 57.32 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The Hospital Acquired Infections (HAIs) market is experiencing robust growth due to several critical drivers. An increased awareness of the need to reduce cross infections and the ongoing prevalence of infectious diseases in healthcare settings are central to this trend. Supportive government initiatives that advocate for enhanced infection control practices further amplify market expansion. The implementation of stringent infection prevention standards at hospital, regional, and national levels fosters a culture of safety and hygiene within medical environments. Additionally, the rising adoption of monitoring solutions is pivotal, as it empowers healthcare providers to take proactive steps in effectively preventing and managing HAIs, thereby reinforcing the overall commitment to improving patient safety and health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hospital-Acquired Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hospital-Acquired Infection Control Market Segments Analysis

Global Hospital-Acquired Infection Control Market is segmented by Product, Application, Technology, Disease, End User and region. Based on Product, the market is segmented into Protective Barrier, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products and Other Infection Control Products. Based on Application, the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Technology, the market is segmented into Phenotypic Methods and Genotypic Methods. Based on Disease, the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection and Others. Based on End User, the market is segmented into Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market is significantly driven by the notable increase in the number of surgical procedures performed globally in recent years. According to the World Health Organization's 2022 data, approximately 330 million major surgeries are conducted each year around the world. This surge can be attributed to various factors, including the rising incidence of obesity and other lifestyle-related health conditions, which often require surgical solutions for effective treatment and management. As more surgeries are performed, the demand for robust infection control measures in hospitals continues to escalate, underscoring the importance of enhancing patient safety and care standards.

Restraints in the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market faces significant restraints primarily because healthcare providers frequently choose to reprocess reusable medical devices to save costs and minimize waste. These devices include various instruments, such as surgical forceps, endoscopes, and stethoscopes. However, this practice raises ongoing concerns about the safety and effectiveness of these reprocessed instruments. As the apprehension surrounding potential risks to patient safety continues to grow, it complicates the market dynamics for infection control solutions, as both healthcare facilities and patients prioritize safer alternatives to ensure better health outcomes and reduce the incidence of hospital-acquired infections.

Market Trends of the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market is witnessing a significant trend with the reintroduction of ethylene oxide sterilization, a key method known for its efficiency in sterilizing temperature-sensitive medical instruments. This resurgence is driven by the increasing demand for effective sterilization methods amid rising hospital-acquired infections, combined with a push for improved infection control protocols. However, the market is also experiencing scrutiny over potential health risks associated with ethylene oxide exposure, prompting regulatory bodies to assess safety standards. As hospitals seek to balance efficacy and safety, advancements in ethylene oxide technology and alternative sterilization methods are anticipated to shape the future dynamics of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hospital-Acquired Infection Control Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Protective Barrier
• Sterilization
• Disinfectants
  • Product
  • Hand Disinfectants
  • Surface Disinfectants
  • Skin Disinfectants
  • Instrument Disinfectants
  • Formulation
  • Liquid Disinfectants
  • Disinfectant Wipes
  • Disinfectant Sprays
• Disinfectors
• Endoscope Reprocessing Products
• Other Infection Control Products

Global Hospital-Acquired Infection Control Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Testing
• Drug-Resistance Testing

Global Hospital-Acquired Infection Control Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Phenotypic Methods
• Genotypic Methods

Global Hospital-Acquired Infection Control Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infection
• Others

Global Hospital-Acquired Infection Control Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & ICUs
• Ambulatory Surgical & Diagnostic Centers
• Nursing Homes & Maternity Centers
• Others

Global Hospital-Acquired Infection Control Market Size & CAGR (2025-2032)

• North America (Product & Services, Application, Technology, Disease, End User)
  • US
  • Canada
• Europe (Product & Services, Application, Technology, Disease, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, Technology, Disease, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, Technology, Disease, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, Technology, Disease, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 3M Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecolab Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Sterilization Products (ASP) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Belimed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matachana Group (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MMM Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrex Research LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miele Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pal International (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melag Medizintechnik GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contec, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDALKAN (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Systec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.B.M. S.r.l. Medical Equipment (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Continental Equipment Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations